Skip to content
ppharmaranks
Menu
Class IIOngoing

Testosterone Regular Release 200 MG recall

FDA recall D-0129-2026 · initiated Oct 14, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Nov 5, 2025How we research

FARMAKEIO OUTSOURCING LLC recalled Testosterone Regular Release 200 MG in Oct 2025 — an FDA Class II recall (D-0129-2026) because CGMP Deviations: Potential presence of metal particulate matter.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations: Potential presence of metal particulate matter

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot, expiry: 3201, Exp 2/7/2026; 3202, Exp 2/21/2026; 3280, Exp 4/8/2026; 3283, Exp /9/2026.

Quantity recalled: 14,329 pellets

Details

Product
Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0402-01
Recalling company
FARMAKEIO OUTSOURCING LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA and Antigua
Initiated
Oct 14, 2025
FDA report date
Nov 5, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Testosterone Regular Release 200 MG recalled?
FARMAKEIO OUTSOURCING LLC recalled Testosterone Regular Release 200 MG in Oct 2025 — an FDA Class II recall (D-0129-2026) because CGMP Deviations: Potential presence of metal particulate matter. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Testosterone Regular Release 200 MG recalled?
Per the FDA enforcement record, the reason for recall D-0129-2026 was: CGMP Deviations: Potential presence of metal particulate matter
Is a recalled Testosterone Regular Release 200 MG dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Testosterone Regular Release 200 MG are affected?
Distributed: Nationwide in the USA and Antigua. The recall covers these lots — Lot, expiry: 3201, Exp 2/7/2026; 3202, Exp 2/21/2026; 3280, Exp 4/8/2026; 3283, Exp /9/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0129-2026.

Source: openFDA Drug Enforcement record D-0129-2026

← All drug recalls